Patients onmalariachemoprophvlaxis withmefoquineshouldbe
informedthatifthesereactionsorchanqestotheirmentau stateoccur
durinqmefloduineuse,to stoptakinqmefoauineand seekmedical
advice immediatety so thatmefioquinecan be replaced bv alternative
malariapreventionmedication.
Adversereactions mavalsooccur after discontinuation ofthedrua.In
asmaunumberof patients.thasbeenreportedthat neuropsvchiatric
reactionse.g.depression,dizzinessorvertigoand loss of baance
mav persistformonthsoruonaer.even after discontinuationofthe
drug.
Tominimisetheriskfortheseadversereactions.mefloauinemustnot
beusedforchemoprophvlaxis in patients with activeorahistomv of
psvchiatric disturbances suchas depression, anxiety disorders.
schizophrenia or other psychiatric disorders
@1MINENDOCRINE
